Amylyx Pharmaceuticals, Inc. AMLX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s operating cash flow?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported operating cash flow of -$36.88M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s operating cash flow changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s operating cash flow increased by 7.4% year-over-year, from -$39.82M to -$36.88M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s operating cash flow has grown at a 13.3% compound annual growth rate (CAGR), from -$74.8M to -$123.34M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.